Literature DB >> 3936741

Determination of serum apo A-IV concentration in patients receiving total parenteral nutrition.

M Seishima, A Mori, M Kawade, F Okuno, T Yoshida, Y Muto.   

Abstract

Serum apolipoprotein (apo) A-IV levels were determined in patients receiving total parenteral nutrition (TPN) by an immunoassay using a specific antiserum against apo A-IV purified from human sera. The value was significantly lower than that of normal subjects (p less than 0.001), and the level correlated significantly with the duration of TPN. In a patient receiving TPN, serum apo A-IV concentration decreased during TPN and returned to normal levels after resuming oral intake of diet. This finding indicates that serum apo A-IV is a new parameter for nutritional assessment, since the protein is exclusively synthesized in the gut, being different from other rapid turnover proteins which are mainly synthesized in the liver.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3936741     DOI： 10.1007/bf02774815

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN： 0435-1339


  15 in total

1.  Apoprotein A-I synthesis in normal intestinal mucosa and in Tangier disease.

Authors:  R M Glickman; P H Green; R S Lees; A Tall
Journal:  N Engl J Med       Date:  1978-12-28       Impact factor: 91.245

2.  Rapid visualization of protein bands in preparative SDS-polyacrylamide gels.

Authors:  R C Higgins; M E Dahmus
Journal:  Anal Biochem       Date:  1979-03       Impact factor: 3.365

3.  The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  K Weber; M Osborn
Journal:  J Biol Chem       Date:  1969-08-25       Impact factor: 5.157

4.  Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.

Authors:  C B Laurell
Journal:  Anal Biochem       Date:  1966-04       Impact factor: 3.365

5.  Apolipoprotein A-IV: a protein occurring in human mesenteric lymph chylomicrons and free in plasma. Isolation and quantification.

Authors:  G Utermann; U Beisiegel
Journal:  Eur J Biochem       Date:  1979-09

6.  Plasma apolipoprotein A-IV levels decrease in patients with chronic pancreatitis and malabsorption syndrome.

Authors:  S Koga; Y Miyata; A Funakoshi; H Ibayashi
Journal:  Digestion       Date:  1985       Impact factor: 3.216

7.  Human apolipoprotein A-IV. Intestinal origin and distribution in plasma.

Authors:  P H Green; R M Glickman; J W Riley; E Quinet
Journal:  J Clin Invest       Date:  1980-04       Impact factor: 14.808

8.  Distribution of apolipoprotein A-IV between the lipoprotein and the lipoprotein-free fractions of rat plasma: possible role of lecithin:cholesterol acyltransferase.

Authors:  J G DeLamatre; C A Hoffmeier; A G Lacko; P S Roheim
Journal:  J Lipid Res       Date:  1983-12       Impact factor: 5.922

9.  Isolation and characterization of human apolipoprotein A-IV from lipoprotein-depleted serum.

Authors:  R B Weinberg; A M Scanu
Journal:  J Lipid Res       Date:  1983-01       Impact factor: 5.922

10.  Cloning of a complementary deoxyribonucleic acid encoding a portion of rat intestinal preapolipoprotein AIV messenger ribonucleic acid.

Authors:  J I Gordon; D P Smith; D H Alpers; A W Strauss
Journal:  Biochemistry       Date:  1982-10-26       Impact factor: 3.162
View more
  2 in total

1.  Alterations in plasma levels of apolipoprotein A-IV in various clinical entities.

Authors:  Y Miyata; S Koga; H Ibayashi
Journal:  Gastroenterol Jpn       Date:  1986-10

2.  Apo AIV and Citrulline Plasma Concentrations in Short Bowel Syndrome Patients: The Influence of Short Bowel Anatomy.

Authors:  M Dolores López-Tejero; Núria Virgili; Jordi Targarona; Jorge Ruiz; Natalia García; Denise Oró; Judit García-Villoria; Gloria Creus; Ana M Pita
Journal:  PLoS One       Date:  2016-09-30       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.